HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carotenoids in erythropoietic protoporphyria and other photosensitivity diseases.

Abstract
Studies in bacteria, animals and humans have demonstrated that carotenoid pigments can prevent or lessen photosensitivity by endogenous photosensitizers such as chlorophyll or porphyrins, as well as by exogenous photosensitizers such as dyes (e.g., toluidine blue) or porphyrin derivatives. The carotenoids beta-carotene and canthaxanthin have been found to be effective in the treatment of the photosensitivity associated with EPP and certain other photosensitivity diseases. No serious toxicity has been reported from their use, although the use of canthaxanthin is not recommended because of its propensity to form retinal granules. The pigments perform their protective function by quenching excited species formed by the interaction of porphyrins or dyes, light and air, thereby preventing the cellular damage which leads to the symptoms of photosensitivity.
AuthorsM M Mathews-Roth
JournalAnnals of the New York Academy of Sciences (Ann N Y Acad Sci) Vol. 691 Pg. 127-38 (Dec 31 1993) ISSN: 0077-8923 [Print] United States
PMID8129282 (Publication Type: Journal Article, Review)
Chemical References
  • beta Carotene
  • Carotenoids
Topics
  • Adolescent
  • Adult
  • Animals
  • Bacteria (metabolism)
  • Carotenoids (metabolism, therapeutic use, toxicity)
  • Child
  • Child, Preschool
  • Humans
  • Infant
  • Photosensitivity Disorders (prevention & control)
  • Porphyria, Hepatoerythropoietic (prevention & control)
  • beta Carotene

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: